Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Msellati

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|December 24, 2005
Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'IvoireMarie-Laure Chaix, François Rouet, Kouakou Alain Kouakoussui, et al.
The Pediatric Infectious Disease Journal|October 27, 2012
Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 countPierre De Beaudrap, Charlotte Boullé, Charlotte Lewden, et al.
International Journal of STD & AIDS|August 13, 2002
Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000Annabel Desgrées-Du-Loû, Philippe Msellati, Ida Viho, et al.
International Journal of STD & AIDS|January 18, 2006
Decrease of human immunodeficiency virus prevalence in antenatal clinics in Abidjan, Côte d'Ivoire, 1995-2002Philippe Msellati, Charlotte Sakarovitch, Laurence Bequet, et al.
Food and Nutrition Bulletin|November 25, 2016
Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort StudyCecile Cames, Marie Varloteaux, Ndeye Ngone Have, et al.
The Journal of Infectious Diseases|May 5, 2016
New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of SurvivorsMamadou S Sow, Jean-François Etard, Sylvain Baize, et al.
Lancet (London, England)|October 16, 2022
Reconsidering the COVID-19 vaccine strategy in West and Central AfricaPhilippe Msellati, Khoudia Sow, Alice Desclaux, et al.
The Pediatric Infectious Disease Journal|February 11, 2017
Risk Factors for Growth Retardation in HIV-infected Senegalese Children on Antiretroviral Treatment: The ANRS 12279 MAGGSEN Pediatric Cohort StudyCecile Cames, Lea Pascal, Aminata Diack, et al.
BMC Public Health|May 22, 2008
18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort studyJérôme Harambat, Patricia Fassinou, Renaud Becquet, et al.
BMC Infectious Diseases|August 8, 2018
Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort StudyCecile Cames, Lea Pascal, Aissatou Ba, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|December 24, 2005
Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'IvoireMarie-Laure Chaix, François Rouet, Kouakou Alain Kouakoussui, et al.
The Pediatric Infectious Disease Journal|October 27, 2012
Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 countPierre De Beaudrap, Charlotte Boullé, Charlotte Lewden, et al.
International Journal of STD & AIDS|August 13, 2002
Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000Annabel Desgrées-Du-Loû, Philippe Msellati, Ida Viho, et al.
International Journal of STD & AIDS|January 18, 2006
Decrease of human immunodeficiency virus prevalence in antenatal clinics in Abidjan, Côte d'Ivoire, 1995-2002Philippe Msellati, Charlotte Sakarovitch, Laurence Bequet, et al.
Food and Nutrition Bulletin|November 25, 2016
Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort StudyCecile Cames, Marie Varloteaux, Ndeye Ngone Have, et al.
The Journal of Infectious Diseases|May 5, 2016
New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of SurvivorsMamadou S Sow, Jean-François Etard, Sylvain Baize, et al.
Lancet (London, England)|October 16, 2022
Reconsidering the COVID-19 vaccine strategy in West and Central AfricaPhilippe Msellati, Khoudia Sow, Alice Desclaux, et al.
The Pediatric Infectious Disease Journal|February 11, 2017
Risk Factors for Growth Retardation in HIV-infected Senegalese Children on Antiretroviral Treatment: The ANRS 12279 MAGGSEN Pediatric Cohort StudyCecile Cames, Lea Pascal, Aminata Diack, et al.
BMC Public Health|May 22, 2008
18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort studyJérôme Harambat, Patricia Fassinou, Renaud Becquet, et al.
BMC Infectious Diseases|August 8, 2018
Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort StudyCecile Cames, Lea Pascal, Aissatou Ba, et al.
Pageof 8